propiconazole has been researched along with selenium in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Fratianni, C; Gonzales, M; Khardori, R; Mamillapali, C | 1 |
Casini, G; Cestari, L; Latrofa, F; Leo, M; Marcocci, C; Marinò, M; Nardi, M; Rotondo Dottore, G; Sellari-Franceschini, S; Vitti, P | 1 |
Casini, G; Cestari, L; Chiarini, R; De Gregorio, M; Leo, M; Marcocci, C; Marinò, M; Nardi, M; Rotondo Dottore, G; Sellari-Franceschini, S; Vitti, P | 1 |
Eckstein, A; Führer, D; Möller, L; Oeverhaus, M | 1 |
2 review(s) available for propiconazole and selenium
Article | Year |
---|---|
Immunotherapy in miscellaneous medical disorders Graves ophthalmopathy, asthma, and regional painful syndrome.
Topics: Allergens; Anti-Asthmatic Agents; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antioxidants; Asthma; Azathioprine; Benzamides; Complex Regional Pain Syndromes; Cyclosporine; Decompression, Surgical; Etanercept; Glucocorticoids; Graves Ophthalmopathy; Humans; Imatinib Mesylate; Immunoglobulin G; Immunoglobulins, Intravenous; Immunosuppressive Agents; Immunotherapy; Octreotide; Omalizumab; Orbit; Piperazines; Pyridones; Pyrimidines; Radiotherapy Dosage; Receptors, Tumor Necrosis Factor; Risk Factors; Rituximab; Selenium | 2012 |
[Graves' orbitopathy].
Topics: Administration, Intravenous; Antibodies, Monoclonal, Humanized; Antioxidants; Decompression, Surgical; Graves Ophthalmopathy; Humans; Lubricant Eye Drops; Orbit; Receptor, IGF Type 1; Risk Factors; Selenium; Smoking Cessation; Steroids | 2021 |
2 other study(ies) available for propiconazole and selenium
Article | Year |
---|---|
Antioxidant Actions of Selenium in Orbital Fibroblasts: A Basis for the Effects of Selenium in Graves' Orbitopathy.
Topics: Aged; Antioxidants; Case-Control Studies; Cell Proliferation; Cells, Cultured; Cytokines; Female; Fibroblasts; Glutathione Disulfide; Glutathione Peroxidase; Graves Ophthalmopathy; Humans; Hyaluronic Acid; Hydrogen Peroxide; Male; Middle Aged; Orbit; Oxidants; Oxidative Stress; Selenium; Selenocysteine | 2017 |
Selenium rescues orbital fibroblasts from cell death induced by hydrogen peroxide: another molecular basis for the effects of selenium in graves' orbitopathy.
Topics: Adipose Tissue; Aged; Cell Death; Cells, Cultured; Cytoprotection; Female; Fibroblasts; Graves Ophthalmopathy; Humans; Hydrogen Peroxide; Male; Middle Aged; Orbit; Primary Cell Culture; Selenium; Signal Transduction | 2017 |